Ich stimme der Verwendung von Cookies zu. Auch wenn ich diese Website weiter nutze, gilt dies als Zustimmung.

Bitte lesen und akzeptieren Sie die Datenschutzinformation und Cookie-Informationen, damit Sie unser Angebot weiter nutzen können. Natürlich können Sie diese Einwilligung jederzeit widerrufen.






21st Austria weekly - Kontron, Marinomed (01/09/2025)

07.09.2025

Kontron: Gobal provider of IoT/Embedded Computing Technology and 5G cellular modems Kontron announced a collaboration with Qualcomm Technologies, Inc. to develop a next-generation 5G FRMCS (Future Railway Mobile Communication System) PC3 modem tailored for the MORANE 2 European railway communications initiative. FRMCS will be the 5G standard for railway operational communications, adaptable to the needs and requirements of rail organizations within Europe and beyond. The Kontron 5G FRMCS modem is based on the Snapdragon® X72 5G Modem-RF System, which delivers unparalleled performance, reliability, and energy efficiency, making it the ideal foundation for FRMCS deployments in rail environments.
Kontron: weekly performance: -1.47%

Marinomed: Marinomed Biotech AG  announces that it has reached a basic agreement with an investor based in Germany on the key terms of an intended issue of convertible bonds to be secured by selected receivables and patents in a nominal value of EUR 2,500,000 and a term of 12 months (extendable to 24 months), which are to be subscribed exclusively by the investor (subject to the exclusion of existing shareholders' subscription rights). The convertible bond shall bear interest at 8.5%, with interest payable at maturity and not being subject to any conversion rights. The convertible bond shall provide for a conversion right into shares of the Company at a conversion price of EUR 15 per share (corresponding to a conversion right in up to 166,666 shares of the Company).
Marinomed Biotech: weekly performance: 0.25%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (01/09/2025)


Partners









latest 21st Austria

21st Austria weekly - Kontron, Marinomed (01/09/2025)


07.09.2025, 1646 Zeichen



Kontron: Gobal provider of IoT/Embedded Computing Technology and 5G cellular modems Kontron announced a collaboration with Qualcomm Technologies, Inc. to develop a next-generation 5G FRMCS (Future Railway Mobile Communication System) PC3 modem tailored for the MORANE 2 European railway communications initiative. FRMCS will be the 5G standard for railway operational communications, adaptable to the needs and requirements of rail organizations within Europe and beyond. The Kontron 5G FRMCS modem is based on the Snapdragon® X72 5G Modem-RF System, which delivers unparalleled performance, reliability, and energy efficiency, making it the ideal foundation for FRMCS deployments in rail environments.
Kontron: weekly performance: -1.47%

Marinomed: Marinomed Biotech AG  announces that it has reached a basic agreement with an investor based in Germany on the key terms of an intended issue of convertible bonds to be secured by selected receivables and patents in a nominal value of EUR 2,500,000 and a term of 12 months (extendable to 24 months), which are to be subscribed exclusively by the investor (subject to the exclusion of existing shareholders' subscription rights). The convertible bond shall bear interest at 8.5%, with interest payable at maturity and not being subject to any conversion rights. The convertible bond shall provide for a conversion right into shares of the Company at a conversion price of EUR 15 per share (corresponding to a conversion right in up to 166,666 shares of the Company).
Marinomed Biotech: weekly performance: 0.25%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (01/09/2025)



BSN Podcasts
Christian Drastil: Wiener Börse Plausch

D&D Research Rendezvous #21: Wir sehen gerade die schnellste Erholungsrally nach einer Korrektur seit 35 Jahren, meint Gunter Deuber




 

Bildnachweis

Aktien auf dem Radar:Rosenbauer, Flughafen Wien, Österreichische Post, EuroTeleSites AG, Kapsch TrafficCom, Polytec Group, Bajaj Mobility AG, AT&S, CPI Europe AG, SBO, Andritz, DO&CO, Erste Group, FACC, Gurktaler AG Stamm, OMV, Palfinger, RBI, Verbund, voestalpine, Wienerberger, Semperit, BKS Bank Stamm, SW Umwelttechnik, BTV AG, Oberbank AG Stamm, Amag, CA Immo, Telekom Austria, RHI Magnesita, DAX.


Random Partner

Societe Generale
Société Générale ist einer der weltweit größten Derivate-Emittenten und auch in Deutschland bereits seit 1989 konstant als Anbieter für Optionsscheine, Zertifikate und Aktienanleihen aktiv. Mit einer umfangreichen Auswahl an Basiswerten aller Anlageklassen (Aktien, Indizes, Rohstoffe, Währungen und Zinsen) überzeugt Société Générale und nimmt in Deutschland einen führenden Platz im Bereich der Hebelprodukte ein.

>> Besuchen Sie 55 weitere Partner auf boerse-social.com/partner


Useletter

Die Useletter "Morning Xpresso" und "Evening Xtrakt" heben sich deutlich von den gängigen Newslettern ab. Beispiele ansehen bzw. kostenfrei anmelden. Wichtige Börse-Infos garantiert.

Newsletter abonnieren

Runplugged

Infos über neue Financial Literacy Audio Files für die Runplugged App
(kostenfrei downloaden über http://runplugged.com/spreadit)

per Newsletter erhalten